PATENT CLAIM ANALYSIS

Application Number: 16226345
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-08
Patent Classification: ["424", "452000"]

Abstract:
Abuse-resistant oral dosage forms suitable for administration of pharmacologically active agents are provided.

Claim (Index 35):
A composition comprising a mixture comprising:\n methylphenidate; sucrose acetate isobutyrate (SAM); a cellulose acetate butyrate (CAB); a rheology modifier selected from isopropyl myristate (IPM), caprylic/capric triglyceride, ethyl oleate, triethyl citrate, dimethyl phthalate, and benzyl benzoate; a saturated polyglycolized glyceride (SPG); and a solvent; wherein the mixture is encapsulated within a capsule.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 98.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14798263', '13786217', '15839428', '12315868', '15853013']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8108785163587814
- 35 USC 102 Novelty (BERT): 0.6366426003507183
- Combined Prediction Score: 0.7934549247579751
- Mean Citation Score: 594.2799660000002
- Max Citation Score: 681.0409
- Similarity Product: 554.2226661695182

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test